Public Calendar: April 30 - May 6, 2017
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.
Official Name : Stephen M. Ostroff, M.D., Acting Commissioner
Event Date : 05/02/2017 - 05/02/2017
Location : Washington, DC
Subject : Discovery's "First In Human" Medical Research Docuseries
FDA Participant/Group : STEPHEN OSTROFF;
Non FDA Participant/Group : N/A
Event Date : 05/03/2017 - 05/03/2017
Location : Washington, DC
Subject : Global Challenge of Antimicrobial Resistance
FDA Participant/Group : STEPHEN OSTROFF;
Non FDA Participant/Group : N/A
Event Date : 05/03/2017 - 05/03/2017
Location : Washington, D.C.
Subject : US-Japan Dialogue: The Center for Strategic and International Studies (CSIS)
FDA Participant/Group : STEPHEN OSTROFF;
Non FDA Participant/Group : N/A
Event Date : 05/04/2017 - 05/04/2017
Location : Washington, DC
Subject : The Reagan-Udall Foundation 2017 Annual Public Meeting
FDA Participant/Group : STEPHEN OSTROFF;
Non FDA Participant/Group : N/A
Official Name : Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis
Event Date : 05/01/2017 - 05/01/2017
Location : Washington, DC
Subject : Rare Diseases Clinical Research Network/Coalition of Patient Advocacy Groups (RDCRN-CPAG)
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A
Official Name : Dara Corrigan, Acting Deputy Commissioner for Global Regulatory Operations and Policy
Event Date : 05/05/2017 - 05/05/2017
Location : Washington, D.C.
Subject : The US-EU Mutual Recognition Agreement to the Food and Drug Law Institute (FDLI) 2017 Annual Conference
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A
Official Name : Jim Sigg, Acting Deputy Commissioner for Operations
No Significant Event
Official Name : Erik Mettler, Acting Deputy Commissioner for Foods and Veterinary Medicine
No Significant Event
Official Name : Melinda Plaisier, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name : Peter Lurie, M.D., M.P.H., Associate Commissioner for Policy and Planning
No Significant Event
Official Name : Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name : Jack Kalavritinos, Associate Commissioner for External Affairs
Event Date : 05/03/2017 - 05/03/2017
Location : Washington, DC
Subject : Elanco Animal Health: Animal Antibiotics and Labeling
FDA Participant/Group : N/A
Non FDA Participant/Group : Jeff Simmons;Jesse J.Sevcik (Elanco);
Event Date : 05/04/2017 - 05/04/2017
Location : Washington, DC
Subject : Food Institute: Grocery Manufacturers Association
FDA Participant/Group : N/A
Non FDA Participant/Group : Greg Ferrara (National Grocery Manufacturers Association);
Official Name : Janice Soreth, Associate Commissioner for Special Medical Programs
No Significant Event
Official Name : Luciana Borio, M.D., Acting Chief Scientist
No Significant Event
Official Name : Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
Event Date : 05/02/2017
Location : Bethesda, MD
Subject : FDA- Project Data Sphere (PDS) Symposium IV
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A
Event Date : 05/04/2017
Location : Washington, DC
Subject : The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) National Meeting
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A
Official Name : Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date : 05/02/2017 - 05/02/2017
Location : Washington, DC
Subject : The Leukemia & Lymphoma Society (LLS) Meeting
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A
Event Date : 05/04/2017 - 05/04/2017
Location : Washington, DC
Subject : The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) Meeting
FDA Participant/Group : CELIA SILVERMAN;
Non FDA Participant/Group : N/A
Official Name : Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
Event Date : 05/04/2017 - 05/04/2017
Location : Washington, DC
Subject : Food & Drug Law Institute (FDLI) Conference
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A
Event Date : 05/05/2017 - 05/05/2017
Location : Silver Spring, MD
Subject : Synthes Quality System
FDA Participant/Group : SALVATORE RANDAZZO; SEAN BOYD; MATTHEW KRUEGER; DANIEL TAMMARIELLO; ROBIN NEWMAN; RICHARD CHERRY; KARYN CAMPBELL; KENNETH CHEN; WILLIAM MACFARLAND;
Non FDA Participant/Group : Gary Pruden, Sarah Deegan, Philip Desjardins,Martin Fitchet, Francois Sallans (Johnson and Johnson);
Official Name : Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition
Event Date : 05/04/2017 - 05/04/2017
Location : Washington, D.C.
Subject : Food and Drug Law Institute Annual Conference
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A
Official Name : Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name : Steven Solomon, Director, Center for Veterinary Medicine
Event Date : 05/01/2017 - 05/01/2017
Location : Rockville, MD
Subject : The Center for Veterinary Medicine (CVM)
FDA Participant/Group : JEANETTE MURPHY; WILLIAM FLYNN; LAURA BRADBARD; TRACEY FORFA;
Non FDA Participant/Group : David Fairfield, Randy Gordon (National Grain and Feed Association);
Event Date : 05/04/2017 - 05/04/2017
Location : Washington, D.C.
Subject : Food and Drug Law Institute
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A
Official Name : William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name : Elizabeth H. Dickinson, Esq., Chief Counsel
No Significant Event